Skip to main content
. 2019 Jun 13;42(8):zsz122. doi: 10.1093/sleep/zsz122

Table 3.

Comparison of the insomnia residual symptoms by subgroups of age and physical conditions at remission point (T2 or T3)

Mean
(SD)
DIS DMS EMA Daytime MorRefr Noticeable Worry QoS
Age: 18–34 0.88
(0.80)
0.99
(0.88)
0.90
(0.85)
1.04
(0.85)
2.19
(0.74)
0.75
(0.75)
0.61
(0.72)
1.35
(0.82)
 35–49 0.85
(0.88)
1.11
(0.81)
0.98
(0.89)
1.12
(0.90)
2.14
(0.77)
0.79
(0.82)
0.61
(0.70)
1.50
(0.78)
 50–59 0.94
(0.84)
1.18
(0.89)
1.02
(0.87)
0.99
(0.80)
2.31
(0.79)
0.61
(0.70)
0.58
(0.72)
1.41
(0.73)
 60–94 0.93
(0.81)
1.11
(0.82)
1.07
(0.81)
0.83
(0.85)
2.55
(0.74)
0.49
(0.73)
0.47
(0.70)
1.24
(0.67)
ANOVA: F 0.26 0.75 0.62 2.12 5.74** 3.38* 0.93 2.28
Physical disease(s)
 No 0.93
(0.80)
1.12
(0.85)
1.00
(0.85)
1.07
(0.85)
2.27
(0.79)
0.71
(0.78)
0.60
(0.73)
1.42
(0.76)
 Yes 0.80
(0.94)
1.02
(0.82)
1.00
(0.87)
0.75
(0.84)
2.37
(0.70)
0.50
(0.70)
0.45
(0.62)
1.25
(0.73)
t-test: t 1.18 0.98 −0.03 3.12** −1.06 2.26* 1.74 1.86
Mean (SD) QoL Fatigue Cognition Interpersonal Mood Activity BDI-II
Age: 18–34 0.85
(0.72)
1.33
(0.90)
1.08
(0.89)
0.91
(0.92)
1.34
(0.89)
1.04
(0.71)
8.75
(8.05)
 35–49 0.99
(0.84)
1.30
(0.95)
1.09
(0.94)
0.84
(0.82)
1.06
(0.99)
0.94
(0.93)
6.88
(7.10)
 50–59 0.78
(0.68)
1.01
(0.77)
0.80
(0.85)
0.55
(0.72)
0.87
(0.76)
0.72
(0.71)
7.95
(8.71)
 60–94 0.65
(0.69)
0.85
(0.81)
0.77
(0.92)
0.38
(0.70)
0.61
(0.72)
0.59
(0.80)
6.58
(5.80)
ANOVA: F 3.96** 6.94*** 3.64* 9.45*** 11.53*** 5.63** 1.66
Physical disease(s)
 No 0.87
(0.76)
1.17
(0.90)
0.99
(0.91)
0.70
(0.82)
0.97
(0.89)
0.83
(0.85)
7.85
(7.66)
 Yes 0.67
(0.71)
0.94
(0.83)
0.75
(0.93)
0.57
(0.80)
0.92
(0.89)
0.76
(0.89)
5.97
(6.47)
t-test: t 2.26* 2.15* 2.20* 1.30 0.51 0.73 2.09*

*p < 0.5; **p < 0.01; ***p < 0.001.

BDI, Beck Depression Inventory; Daytime, ISI impairments daytime; DIS, difficulties with initiating sleep; DMS, difficulties maintaining sleep; EMA, early morning awakenings; MorRefr, ISI morning refreshment; QoL, quality of life; QoS, sleep quality.